Compounds with a combination of cannabinoid-CB1 antagonism and acetylcholinesterase inhibition

Details for Australian Patent Application No. 2007336219 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Kruse, Cornelis G.; Shadid, Belal; Lange, Josephus H.M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007336219

PCT Pub. Number WO2008/074816

Priority 60/875,808 20.12.06 US; 06126584.9 20.12.06 EP

Filing date 19 December 2007

Wipo publication date 26 June 2008

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/074816 Priority application(s): WO2008/074816

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007336220-Method for optimising the sharing of a plurality of network resources between a plurality of application flows

2007336213-System for generating electrical power and potable water from sea waves